Global Community
Our community narratives are driven by numbers and valuation.
Community Investing Ideas
Global Weekly Picks
Oncolytics Biotech
74.9% undervalued intrinsic discount
The Team Behind a $2 Billion Johnson & Johnson (JNJ) Deal Just Took Over This $105 Million Cancer Biotech
View narrativeLO
Published 18 Aug
ServiceNow
19.6% undervalued intrinsic discount
The Platform Turning Enterprise Chaos into Autonomous Workflows
View narrativeAN
Published 15 Aug
Vistra
50.8% undervalued intrinsic discount
New
Vistra Fell 38%. Adjusted EBITDA Rose 31%. Here's the $472 Million Reason They Disagree.
View narrativeJO
Published 31 Aug
EverQuote
29.3% undervalued intrinsic discount
EverQuote and an Asymmetric Investment Opportunity
View narrativeHA
Published 20 Aug
Dusk Group
16.7% overvalued intrinsic discount
Dusk Group (ASX: DSK) — FY26: A Better Business With Less Money. No Margin of Safety at Current Price
View narrativeAN
Published 20 Aug
Elm
1.8% undervalued intrinsic discount
Elm poised for a promising 3-year growth with 21.7% future PE surge
View narrativeVA
Published 13 Aug
Alphabet
11.3% overvalued intrinsic discount
Negative Free Cash Flow For The First Time In A Second Quarter
View narrativeRC
Published 5 Aug
Resonance Health
27.7% undervalued intrinsic discount
New
Resonance Health will triple revenue growth to 30.83% in five years
View narrativeDA
Published 29 Aug
Booking Holdings
34.1% undervalued intrinsic discount
New
The Float Illusion: How Booking Holdings Almost Talked Me Into a $130-a-Share Mistake
View narrativeJO
Published 3 Sep
Amazon.com
9.0% undervalued intrinsic discount
Record Profit And Negative Free Cash Flow, Same Quarter
View narrativeRC
Published 5 Aug
Eaton
24.4% undervalued intrinsic discount
New
"Grid-to-Chip: How Eaton Controls the Physical Bottlenecks of AI Data Centers"
View narrativeCO
Published 29 Aug
Dr. Sulaiman Al Habib Medical Services Group
13.6% undervalued intrinsic discount
Dr. Sulaiman Al Habib Medical worth it or not ?
View narrativeVA
Published 7 Aug
Rheinmetall
81.4% undervalued intrinsic discount
Rheinmetall AG: 2029 Valuation Outlook — €2,900–€6,800 per Share
View narrativeBA
Published 24 Aug
